查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1496723

神经血管介入器材的全球市场：按产品、工艺、适应症和最终用途 - 预测（2024-2030）

Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Indication, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球神经血管介入器材市场规模为40.1亿美元，2024年达42.5亿美元，2030年达62.1亿美元，复合年增长率为6.46%。

神经血管介入设备是先进的医疗设备，旨在治疗影响大脑和神经系统血管的神经血管疾病。这些医疗设备可以对动脉瘤、动静脉畸形 (AVM) 和缺血性中风等疾病进行微创手术。这些包括支架、栓塞弹簧圈、分流器、微导管和血栓移除装置。由于神经血管疾病的复杂性和神经系统的关键功能，这些仪器的使用需要高精度和熟练的介入性神经科。中风、动脉瘤和狭窄等神经血管疾病的盛行率不断增加，增加了对神经血管介入设备的需求。微创手术因其住院时间短、恢復时间短、併发症风险低等优点，比传统手术越来越受到青睐。神经血管介入的成功很大程度上取决于熟练专业人员和先进医疗基础设施的可用性，而某些地区可能缺乏这些基础设施。神经血管介入需要高精度和技术。然而，设备设计和性能的技术限制，例如复杂血管结构中的导航困难，可能会导致手术併发症。领先的公司正在进行持续的研究和开发，旨在创造更先进、可靠和安全的神经血管介入设备。其中包括改进的导航功能、更有效的血栓清除以及加速血管癒合的设备。将人工智慧和机器人技术整合到神经血管介入中可以提高准确性、减少手术时间并改善患者的治疗效果。

主要市场统计
基准年[2023] 40.1亿美元
预计年份 [2024] 42.5亿美元
预测年份 [2030] 62.1亿美元
复合年增长率（%） 6.46%

区域洞察

以美国和加拿大为中心的美洲地区由于先进的医疗基础设施、较高的患者意识以及大量的研发投资，是神经血管介入器材高度发达的地区。该地区的客户正在寻求能够快速康復的创新微创解决方案，并且需要具有经过验证的功效和安全性的产品。美国最近的专利专注于提高设备精度和减少手术併发症。儘管设备的核准程序很严格，但加拿大的全民健保系统支持患者获得这些治疗。由于医疗保健支出的增加，亚太地区神经血管介入设备市场正在迅速扩大。老化人口中神经系统疾病的日益流行也推动了神经血管介入设备的采用。本土製造商正大力投资研发，以与国际品牌竞争。日本因其高额医疗支出和先进技术而成为亚太地区的主要贡献者，患者对有临床证据支持的创新有着强烈的渴望。印度市场的特点是，由于医疗意识的提高和医疗基础设施的改善，对神经血管治疗的需求不断增长。欧盟的患者通常需要高品质且耐用的神经血管设备。欧盟最近的倡议着重于协调监管要求，以简化设备核准流程，使製造商和患者受益。有关医疗设备性能、功效、安全性和製造的严格法规为神经血管介入器械的进步和采用创建了标准化框架。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在神经血管介入设备市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对神经血管介入器材市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在神经血管介入器械市场中的地位进行全面评估可以帮助公司做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球神经血管疾病的发生率增加
      • 人们对微创手术的兴趣日益浓厚
    • 抑制因素
      • 神经血管介入器材缺乏报销场景和产品召回
    • 机会
      • 神经血管介入器材的技术进展
      • 增加神经血管研发和治疗中心的投资
    • 任务
      • 神经血管介入装置操作的技术限制
  • 市场区隔分析
    • 产品：导管在各类血管内神经外科手术的基本作用
    • 流程：扩大神经血管介入器材在脑血管造影术的使用
    • 症状：用于治疗缺血性中风的神经血管介入装置的使用迅速增加
    • 最终用途：医院综合设备和专业人员扩大神经血管介入设备的部署
  • 市场趋势分析
    • 美洲神经血管医疗基础设施的进步和成熟的介入设备提供者的存在
    • 技术创新和强大的医疗基础设施推动神经血管介入设备在亚太地区的使用
    • 欧洲、中东和非洲对神经血管介入器材的监管核准增加
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章神经血管介入设备市场：副产品

  • 气球系统
  • 颈动脉支架
  • 导管
  • 栓塞弹簧圈
  • 栓塞防护装置
  • 分流器
  • 导管导引线
  • 颅内支架
  • 囊内装置
  • 神经血栓切除装置

第七章神经血管介入设备市场：依流程

  • 颈动脉切除术
  • 脑血管血管造影术
  • 卷绕
  • 流晶粒版本
  • 显微外科夹闭
  • 神经血栓切除术
  • 支架

第八章神经血管介入设备市场：依情况分类

  • 动静脉畸形
  • 脑动脉瘤
  • 缺血性中风
  • 狭窄治疗

第九章神经血管介入设备市场：依最终用途分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第十章美洲神经血管介入器材市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太神经血管介入器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲神经血管介入器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • Baylis Medical Technologies 推出 PowerWire Pro 射频导管导引线以增强静脉支架再通
    • S3V Vascular Technologies 获得了 300 亿卢比的 B 轮资金筹措，用于神经血管介入创新，吸引了精英投资者的兴趣。
    • Nanoflex Robotics 推出用于神经血管介入的创新远端控制系统
    • Zylox-Tonbridge 与 Avinger 建立策略伙伴关係，推动大中华区神经血管介入创新
    • 飞利浦推出先进的 Azurion 神经双翼干预系统
    • 推出 CEREGLIDE 71 - CERENOVUS 的 TruCourse 技术在中风介入上取得突破
    • Obasnaich 和 Abbott CSI 将美国独家分销合作伙伴关係延长至 2027 年
    • Sensome 和 Asahi Intecc 合作开发由人工智慧驱动的先进 Clotild 智慧导丝
    • Stryker 收购 Cerus Endoangio 扩大神经血管介入产品范围
    • Infinity Neuro 的 Inspira 抽吸导管获得 CE 标誌

第14章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-ED54C46E8FA1

[183 Pages Report] The Neurovascular Intervention Devices Market size was estimated at USD 4.01 billion in 2023 and expected to reach USD 4.25 billion in 2024, at a CAGR 6.46% to reach USD 6.21 billion by 2030.

Neurovascular intervention devices are advanced medical apparatuses designed for the treatment of neurovascular disorders that affect the blood vessels in the brain and the nervous system. These devices enable minimally invasive procedures for conditions such as aneurysms, arteriovenous malformations (AVMs), and ischemic strokes. They include stents, embolic coils, flow diverters, microcatheters, and clot retrieval devices. The application of these devices requires high precision and skilled interventional neurologists due to the complex nature of neurovascular diseases and the critical function of the nervous system. The rising prevalence of neurovascular conditions, including strokes, aneurysms, and stenosis, has driven the need for neurovascular intervention devices. There is a growing inclination toward minimally invasive surgeries over traditional surgeries due to benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications. The successful implementation of neurovascular interventions is highly dependent on the availability of skilled professionals and advanced healthcare infrastructure, which can be lacking in some regions. Neurovascular interventions require high precision and skill. However, technical limitations in device design and performance, such as navigation difficulties in complex vascular structures, can lead to procedural complications. Key players are exploring ongoing research and development efforts aimed at creating more advanced, reliable, and safer neurovascular intervention devices. These include devices with improved navigability, effectiveness in clot removal, and devices that promote faster vessel healing. The integration of AI and robotics in neurovascular interventions can enhance precision, reduce procedure times, and potentially improve patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 4.01 billion
Estimated Year [2024] USD 4.25 billion
Forecast Year [2030] USD 6.21 billion
CAGR (%) 6.46%

Regional Insights

The Americas region, particularly the U.S. and Canada, presents a highly developed landscape for neurovascular intervention devices due to its advanced healthcare infrastructure, high patient awareness, and significant investment in R&D. Customers here require innovative, minimally invasive solutions that offer quick recovery and have a strong preference for products with proven efficacy and safety. Recent patents in the U.S. have focused on enhancing device accuracy and reducing procedural complications. Canada's universal healthcare system supports patient access to these interventions, although the device approval process can be stringent. APAC's neurovascular intervention devices market is rapidly expanding, owing to its growing healthcare expenditure. The increased prevalence of neurological disorders among its aging population also necessitated the adoption of neurovascular intervention devices. Local manufacturers are investing heavily in R&D, striving to compete with international brands. Japan is a major contributor in the Asia-Pacific region due to its high healthcare spending and technological sophistication, and patients strongly prefer innovation backed by clinical evidence. The Indian market is characterized by a growing need for neurovascular treatments due to increasing healthcare awareness and improving healthcare infrastructure. EU patients generally seek high-quality, durable neurovascular devices. Recent EU initiatives have focused on harmonizing regulatory requirements to streamline device approval processes, benefitting manufacturers and patients. Stringent regulations pertaining to the performance, efficacy, safety, and manufacture of medical devices have created a standardized framework for the progress and adoption of neurovascular intervention devices.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Neurovascular Intervention Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing incidence of neurovascular diseases worldwide
      • Growing preference for minimally invasive procedures
    • Market Restraints
      • Lack of reimbursement scenario and product recall for neurovascular intervention devices
    • Market Opportunities
      • Technological advancements in neurovascular intervention devices
      • Rising investments in neurovascular R&D and treatment center
    • Market Challenges
      • Technical limitations of operating neurovascular intervention devices
  • Market Segmentation Analysis
    • Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
    • Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
    • Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
    • End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Neurovascular Intervention Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Neurovascular Intervention Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization

Baylis Medical Technologies Inc., announced the 510(k) clearance and subsequent launch of its PowerWire Pro Radiofrequency (RF) Guidewire in the United States. Specifically engineered for venous stent recanalization in cases of complete occlusion, this innovative device utilizes radiofrequency technology to navigate through totally occluded peripheral vessel stents. [Published On: 2024-03-20]

S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest

S3V Vascular Technologies secured a robust financial investment of INR 300 crore in Series B funding. The investment highlights a growing confidence in S3V Vascular Technologies' innovative approaches and product offerings in the neurovascular domain. This capital contributes to expanding the company's product line, enhancing its research and development capabilities, and broadening its market reach, particularly in the neurovascular intervention space. [Published On: 2024-03-15]

Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions

Nanoflex Robotics, a Switzerland-based innovator, deployed its remote-capable robotics system at the Jacobs Institute in Buffalo, USA, marking a significant advancement in neurovascular intervention technology. The system integrates a compact magnetic field generator with a navigation control unit, enabling physicians to precisely control, maneuver, and guide ultra-flexible devices through the intricate pathways of the body's vasculature. This breakthrough technology facilitates a wide array of complex vascular interventions by allowing direct manipulation of the guidewire's tip, dramatically enhancing the precision and safety of these procedures. [Published On: 2024-03-11]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Neurovascular Intervention Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Asahi Intecc Co., Ltd., Balt Group, Boston Scientific Corporation, Carl Zeiss AG, Edwards Lifesciences Corporation, Evasc Medical Systems Corp., GE Healthcare, Imperative Care Inc., Integer Holdings Corporation, Japan Lifeline Co., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Nanoflex Robotics AG, NeuroSafe Medical Co., Ltd., Penumbra, Inc., Phenox GmbH by Wallaby Medical, LLC, Rapid Medical Ltd., Route 92 Medical, Inc., Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Balloon Systems
    • Carotid Stents
    • Catheters
    • Embolic Coils
    • Embolic Protection Devices
    • Flow Diverters
    • Guidewires
    • Intracranial Stents
    • Intrasaccular Devices
    • Neurothrombectomy Devices
      • Aspiration Devices
      • Stent Retrievers
      • Ultrasound-assisted Devices
  • Process
    • Carotid Endarterectomy
    • Cerebral Angiography
    • Coiling
    • Flow Diversion
    • Microsurgical Clipping
    • Neurothrombectomy
    • Stenting
  • Indication
    • Arteriovenous Malformations
    • Cerebral Aneurysms
    • Ischemic Strokes
    • Stenosis Treatment
  • End-use
    • Ambulatory Surgical Centers
    • Hospitals
    • Speciality Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of neurovascular diseases worldwide
      • 5.1.1.2. Growing preference for minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement scenario and product recall for neurovascular intervention devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neurovascular intervention devices
      • 5.1.3.2. Rising investments in neurovascular R&D and treatment center
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of operating neurovascular intervention devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
    • 5.2.2. Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
    • 5.2.3. Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
    • 5.2.4. End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
  • 5.3. Market Trend Analysis
    • 5.3.1. Advancing neurovascular healthcare infrastructure in the Americas and the presence of established intervention device providers
    • 5.3.2. Technological innovations and robust healthcare infrastructure driving use of neurovascular intervention devices in the APAC region
    • 5.3.3. Growing approvals for neurovascular intervention devices from regulatory authorities in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Neurovascular Intervention Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Balloon Systems
  • 6.3. Carotid Stents
  • 6.4. Catheters
  • 6.5. Embolic Coils
  • 6.6. Embolic Protection Devices
  • 6.7. Flow Diverters
  • 6.8. Guidewires
  • 6.9. Intracranial Stents
  • 6.10. Intrasaccular Devices
  • 6.11. Neurothrombectomy Devices

7. Neurovascular Intervention Devices Market, by Process

  • 7.1. Introduction
  • 7.2. Carotid Endarterectomy
  • 7.3. Cerebral Angiography
  • 7.4. Coiling
  • 7.5. Flow Diversion
  • 7.6. Microsurgical Clipping
  • 7.7. Neurothrombectomy
  • 7.8. Stenting

8. Neurovascular Intervention Devices Market, by Indication

  • 8.1. Introduction
  • 8.2. Arteriovenous Malformations
  • 8.3. Cerebral Aneurysms
  • 8.4. Ischemic Strokes
  • 8.5. Stenosis Treatment

9. Neurovascular Intervention Devices Market, by End-use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Speciality Clinics

10. Americas Neurovascular Intervention Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Neurovascular Intervention Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Neurovascular Intervention Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization
    • 13.3.2. S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest
    • 13.3.3. Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions
    • 13.3.4. Zylox-Tonbridge Forms Strategic Alliance with Avinger to Innovate Neurovascular Interventions in Greater China
    • 13.3.5. Philips Unveils Advanced Azurion Neuro Biplane Interventional System
    • 13.3.6. Introducing CEREGLIDE 71 a CERENOVUS's Breakthrough in Stroke Intervention with TruCourse Technology
    • 13.3.7. OrbusNeich and Abbott's CSI Extend Exclusive Distribution Partnership in the U.S. through 2027
    • 13.3.8. Sensome and Asahi Intecc Collaborate on Advanced AI-Powered Clotild Smart Guidewire
    • 13.3.9. Stryker's Acquired Cerus Endovascular to Expand its Offering in the Neurovascular Intervention Sector
    • 13.3.10. Infinity Neuro Secures CE Mark for Inspira Aspiration Catheters

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 157. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 170. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 180. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 181. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 182. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 187. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 190. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 191. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 192. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 193. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 197. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 200. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 201. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 202. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 203. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 206. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 210. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 212. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 216. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 217. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 220. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 221. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 222. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 223. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 230. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 232. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 236. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 237. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 240. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 241. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 242. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 243. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 246. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 247. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 248. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 249. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 250. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 251. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 252. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 253. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 256. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 257. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 260. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 261. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 262. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 263. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 279. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 282. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 283. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 284. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 285. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 288. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 289. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2023 (USD MILLION)
  • TABLE 292. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2024-2030 (USD MILLION)
  • TABLE 293. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2023 (USD MILLION)
  • TABLE 294. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2024-2030 (USD MILLION)
  • TABLE 295. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATIO